avr118
Biologicalexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2005 (NCT00127517)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearImmunity, active
Unclear immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- avr118
- avr118
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01206335 | Phase 2 | Sep 1, 2010 | OHR Pharmaceutical, University of Ottawa |
| NCT00765466 | Phase 2 | Oct 1, 2007 | Advanced Viral Research Corp, McGill University |
| NCT00127517 | Phase 2 | Mar 1, 2005 | Advanced Viral Research Corp |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Advanced Viral Research Corp | For profit | 2 | 1 | 1 | 2005 |
| McGill University | Academic/Hospital | 1 | 1 | 1 | 2007 |
| OHR Pharmaceutical | For profit | 1 | 1 | 1 | 2010 |
| University of Ottawa | Academic/Hospital | 1 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1